期刊文献+

Diarrhea after bariatric procedures:Diagnosis and therapy 被引量:1

下载PDF
导出
摘要 Diarrhea after bariatric procedures, mainly those with malabsorptive elements including Roux-Y Gastric Bypass and Biliopancreatic Diversion, is common and an essential determinant of quality of life and microand macronutrient deficiencies. Bariatric surgery is the only sustainably successful method to address morbid obesity and its comorbidities, particularly gaining more and more importance in the specific treatment of diabetic patients. Approximately half a million procedures are annually performed around the world, with numbers expected to rise drastically in the near future. A multitude of factors exert their influence on bowel habits; preoperative comorbidities and procedure-related aspects are intertwined with postoperative nutritional habits. Diagnosis may be challenging owing to the characteristics of postbariatric surgery anatomy with hindered accessibility of excluded segments of the small bowel and restriction at the gastric level. Conventional testing measures, if available, generally yield low accuracy and are usually not validated in this specific population. Limited trials of empiric treatment are a practical alternative and oftentimes an indispensable part of the diagnostic process. This review provides an overview of causes for chronic post-bariatric surgery diarrhea and details the particularities of its diagnosis and treatment in this specific patient population. Topics of current interest such as the impact of gut microbiota and the influence of bile acids on morbid obesity and especially their role in diarrhea are highlighted in order to provide a better understanding of the specific problems and chances of future treatment in post-bariatric surgery patients. Diarrhea after bariatric procedures, mainly those with malabsorptive elements including Roux-Y Gastric Bypass and Biliopancreatic Diversion, is common and an essential determinant of quality of life and micro- and macronutrient deficiencies. Bariatric surgery is the only sustainably successful method to address morbid obesity and its comorbidities, particularly gaining more and more importance in the specific treatment of diabetic patients. Approximately half a million procedures are annually performed around the world, with numbers expected to rise drastically in the near future. A multitude of factors exert their influence on bowel habits; preoperative comorbidities and procedure-related aspects are intertwined with postoperative nutritional habits. Diagnosis may be challenging owing to the characteristics of post-bariatric surgery anatomy with hindered accessibility of excluded segments of the small bowel and restriction at the gastric level. Conventional testing measures, if available, generally yield low accuracy and are usually not validated in this specific population. Limited trials of empiric treatment are a practical alternative and oftentimes an indispensable part of the diagnostic process. This review provides an overview of causes for chronic post-bariatric surgery diarrhea and details the particularities of its diagnosis and treatment in this specific patient population. Topics of current interest such as the impact of gut microbiota and the influence of bile acids on morbid obesity and especially their role in diarrhea are highlighted in order to provide a better understanding of the specific problems and chances of future treatment in post-bariatric surgery patients.
出处 《World Journal of Gastroenterology》 SCIE CAS 2017年第26期4689-4700,共12页 世界胃肠病学杂志(英文版)
  • 相关文献

参考文献2

二级参考文献109

  • 1Jackie D Wood.Neuropathophysiology of functional gastrointestinal disorders[J].World Journal of Gastroenterology,2007,13(9):1313-1332. 被引量:17
  • 2Barnes N M,Sharp T.A review of central 5-HT receptors and their functionNeuropharmacology,1999.
  • 3Longstreth GF,Thompson WG,Chey WD,et al.Functional bowel disordersGastroenterology,2006.
  • 4Komiyama Y,Nakae S,Matsuki T,et al.IL-17 plays an important role in the development of experimental autoimmune encephalomyelitisThe Journal of Immunology,2006.
  • 5Mosmann T R,Coffman R L.THl and TH2 cells: different patterns of lymphokine secretion lead to different functional propertiesAnnual Review of Immunology,1989.
  • 6Nobaek S;Johansson ML;Molin G.Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome,2000(05).
  • 7Malinen E;Rinttila T;Kajander K.Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR,2005(02).
  • 8Khan WI;Blennerhassett PA;Deng Y.IL-12 gene transfer alters gut physiology and host immunity in nematode-infected mice,2001(01).
  • 9Drossman DA;Camilleri M;Mayer EA;Whitehead WE.AGA technical review on irritable bowel syndrome,2002.
  • 10Barbara G,Stanghellini V,De Giorgio R,Cremon C,Cottrell GS,Santini D,Pasquinelli G,Morselli-Labate AM,Grady EF,Bunnett NW,Collins SM,Corinaldesi R.Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology . 2004

共引文献64

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部